Evidence map›Paper›PMID 40225745›Full record

ArticleTransplantation direct2025

Recipient 3-Hepatic Vein Technique with Graft Venoplasty to Maximize Venous Outflow in Left Lobe Living Donor Liver Transplantation.

Yuki Miyazaki, Masato Fujiki, Munkhbold Tuul, Mazhar Khalil, Alejandro Pita, Jaekeun Kim, Andrea Schlegel, Choon H D Kwon, Federico Aucejo, Antonio D Pinna and 2 more

Abstract read
In one paragraph

Article in Transplantation direct, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuki MiyazakiDepartment of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH.ORCID https://orcid.org/0000-0003-2412-1854
Masato FujikiDepartment of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH.
Munkhbold TuulDepartment of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH.
Mazhar KhalilDepartment of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH.
Alejandro PitaDepartment of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH.
Jaekeun KimDepartment of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH.
Andrea SchlegelDepartment of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH.
Choon H D KwonDepartment of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH.
Federico AucejoDepartment of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH.
Antonio D PinnaAbdominal Transplant Center, Cleveland Clinic Florida, Weston, FL.
Charles MillerDepartment of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH.
Koji HashimotoDepartment of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Augmentation of hepatic venous outflow is crucial in living donor liver transplantation (LDLT) to maximize functional graft size and prevent venous complications. We present details of our outflow augmentation technique for left lobe grafts (LLG) in adult LDLTs, which uses all recipient 3 hepatic veins and venoplasty of graft left and middle hepatic veins. This study examines the effectiveness of our technique in preventing outflow complications and the correlation between anatomical variations of the graft hepatic veins and surgical outcomes. Methods: We retrospectively reviewed 88 patients who underwent LLG-LDLT between 2012 and 2023. The patients were classified into 3 groups based on the graft hepatic vein anatomy and usage of venoplasty: group 1 (n = 10, common trunk without venoplasty), group 2 (n = 62, common trunk with venoplasty), and group 3 (n = 16, no common trunk with venoplasty). Results: No patient developed clinically significant venous outflow complications or graft loss related to venous outflow. There were no significant differences in complication rates or ascites production among the groups. Five-year graft survival was comparable among the groups ( Conclusions: The recipient 3 hepatic vein outflow augmentation technique with graft venoplasty can be applied to various graft hepatic venous anatomy and effectively prevents outflow-related graft loss in LLG-LDLT.

Identifiers

PMID40225745
PMCPMC11984780

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.